Interferon-gamma (IFN-gamma) is a pleotropic cytokine released by T-ly
mphocytes and natural killer cells. Normally, these cells do not trave
rse the blood-brain barrier at appreciable levels and, as such, IFN-ga
mma is generally undetectable within the central nervous system (CNS).
Nevertheless, in response to CNS infections, as well as during certai
n disorders in which the CNS is affected, T-cell traffic across the bl
ood-brain barrier increases considerably, thereby exposing neuronal an
d glial cells to the potent effects of IFN-gamma. A large portion of t
his article is devoted to the substantial circumstantial and experimen
tal evidence that suggests that IFN-gamma plays an important role in t
he pathogenesis of the demyelinating disorder multiple sclerosis (MS)
and its animal model experimental allergic encephalomyelitis (EAE). Mo
reover, the biochemical and physiological effects of IFN-gamma are dis
cussed in the context of the potential consequences of such activities
on the developing and mature nervous systems.